Is the age of diagnosis of esophageal adenocarcinoma getting younger? Analysis at a tertiary care center

Authors:

Abstract
There are emerging data that patients R = 0.133, P = 0.05). Characteristics of those 50 years showed no difference in tumor grade. Among the 179 eligible patients in the cancer registry, there was no significant difference in clinical or pathological stage for patients P value = 0.18). There was no association between diagnosis age and survival (P = 0.24). A substantial subset of patients with EAC is diagnosed at <50 years. There was no increasing trend of EAC in younger cohorts from 1991 to 2018. We could not identify more advanced stage tumors in the younger cohort. There was no significant association between diagnosis age and survival.
Funding Information
  • NIH (P30CA016520, P30-DK050306)
  • NCI (U54-CA163004)

This publication has 19 references indexed in Scilit: